tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robbie Marcus, 150 are a BUY (65.22%), 64 are a HOLD (27.83%), 16 are a SELL (6.96%).
Analyst Robbie Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 62.89% that have a potential upside of 19.87% achieved within 140 days.
Robbie Marcus’s has documented 453 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ATRC, AtriCure at 17-Dec-2024.
Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
1 years 4 months 18 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
2 years 4 months 10 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
2 years 6 months 2 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
3 years 1 months 15 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
3 years 9 months 7 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus is most bullish on?
Which stock is Robbie Marcus is most reserved on?
What Year was the first public recommendation made by Robbie Marcus?
